Searched for
SYSTEMATIX RESEARCH
Further price hikes likely in food, personal care products as raw material costs rise: ReportPrices of everyday products are set to increase. Companies face rising raw material costs, leading to hikes and smaller product sizes. Food...- WPI inflation crossing 10% mark not a tail risk but a near-term base case: ReportThe recent Rs 3 hike in petrol and diesel prices, announced after the Prime Minister's national exhortation for austerity, was widely antic...
- Drugs at your door: Signs of a disruption taking shape in IndiaIndia Pharmacy Retail Quick Commerce: India's medicine delivery is seeing a change. Quick-commerce apps are making it easier to buy medicin...
- Pharma stocks buck market weakness as Dr Reddy's gainsPharma stocks showed strength on Thursday, defying market weakness. Dr Reddy's Laboratories saw significant gains, fueled by anticipation o...
- Your smart investment playbook for FY27: What to buy, what to avoid and how to diversify after a rough FY26FY26 left your equity portfolio bruised. As FY27 begins, here’s how to heal it.
- Pharma calls in sick after Trump’s 100% tariff threatPharma stocks fell Thursday after reports of US President Donald Trump mulling 100% tariffs on imported branded and patented medicine maker...
- Petrol Price Hike: Indian oil companies raise premium petrol rates by up to Rs 2.35 per litrePremium petrol prices have seen an increase of up to Rs 2.35 per litre, effective immediately. This hike by oil marketing companies comes a...
- India's crude imports took a big hit due to the West Asia Crisis: Systematix ResearchIndia's crude oil imports saw a sharp decline in early March amid disruptions in West Asia, noted a report by Systematix Research, highligh...
- Oil prices to hit $150? How Indian stock markets may react as Iran war rages onOil prices have surged past $100 per barrel amid escalating Iran–Israel tensions and fears of a prolonged closure of the Strait of Hormuz, ...
- Paint prices may rise 2-5% in April if crude cost remains high: ReportIndian paint prices could rise by 2 to 5 percent next month. This potential increase hinges on crude oil prices remaining high. Dealers ant...
- SRF, Welspun Living among 12 midcap picks by Systematix Research with upside potential of up to 53%Systematix Research expects healthy YoY momentum in the Indian speciality chemicals sector in Q3FY26, driven by volume growth and capex com...
- US FDA review boosts odds for Wockhardt’s NCE success story: Vishal ManchandaWockhardt’s breakthrough respiratory drug Zaynich moves a step closer to market as the US FDA accepts it for review, boosting approval odds...
- GST cuts to boost economy, but revenue loss could hit banking sector: ReportA Systematix Research report indicates that reduced GST rates could cost the government ₹1.2 trillion, potentially limiting capital expendi...
- GST reforms to boost affordability and consumption across sectors: ReportGST reforms are coming soon. Systematix Research reports that food, consumer durables, and automobiles will benefit. Construction, healthca...
- How falling household savings affect the economyWith government expenditure needs exceeding the revenues, the savings were negative. Government dissaving has averaged 2.1% of GDP in the p...
- Exicom Tele-Systems files draft papers with Sebi to garner funds via IPOAlso, the company plans to raise Rs 80 crore through a pre-IPO placement round. If such placement is undertaken, the fresh issue size will ...
- Sugar stocks surge up to 10% on firm price forecastsAvadh Sugar & Energy surged 10%. Uttam Sugar Mills, Dalmia Bharat, Shree Renuka Sugar, and Dhampur Sugar Mills rose between 5% and 6%. Balr...
- Downgrades drag Divi's Laboratories to 2-year lowShares of the Hyderabad-based pharmaceutical ingredient company closed at ₹3,297 apiece on the NSE. The stock touched an intraday low of ₹3...
- Timken’s ABC buyout will pay off in a couple of years: Priyaranjan, Systematix Instl Equity ResearchThey have just expanded the capacity in anticipation of growth coming in the next couple of years
- Franklin Templeton PE invests Rs 45 cr in drug-maker Symbiotec PharmalabSymbiotec is engaged in research, development, manufacturing and marketing of research-based active pharmaceutical ingredients for corticos...
Load More
